ShabinaRoohi(Siddique)AhmedMD

Diabetes, Obesity, Thyroid

Medical Director, Johns Hopkins Community Physicians Endocrinology at Downtown Bethesda; Assistant Professor, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Ahmed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ahmed's full profile

Already have an account?

Office
7315 Wisconsin Avenue
Suite 700
Bethesda, MD 20814
Phone+1 240-235-9120

Fax+1 410-367-2197
Is this information wrong?

Education & Training

Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2012
Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
Johns Hopkins University School of MedicineClass of 2006

Certifications & Licensure

MD State Medical License 2011 - 2024
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Academy of Clinical Excellence Johns Hopkins Community Physicians, 2022
Washingtonian Top Doctor Washingtonian Magazine, 2015-2021
Consultant of the Year 2017 Johns Hopkins Medicine, 2017

Publications & Presentations

PubMed

14 citations
Effects of the low carbohydrate, high fat diet on glycemic control and body weight in patients with type 2 diabetes: experience from a community-based cohort
Shabina Ahmed, Sridevi Bellamkonda, Mihail Zilbermint, Jiangxia Wang, Rita R. Kalyani> ;BMJ Open Diabetes Research & Care. 2020 Mar 1
4 citations
Nivolumab-induced autoimmune diabetes mellitus and hypothyroidism in a patient with rectal neuroendocrine tumor.
Waqas Haque, Shabina Ahmed, Mihail Zilbermint> ;Journal of Community Hospital Internal Medicine Perspectives. 2020 Aug 2
13 citations
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated T...
Razelle Kurzrock, Douglas W. Ball, Marianna Zahurak, Barry D. Nelkin, Vivek Subbiah, Shabina Ahmed, Ashley O'Connor, Enusha Karunsena, Rose Parkinson, Justin A. Bishop...> ;Clinical Cancer Research. 2019 Sep 15
15 citations
Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer
Douglas W. Ball, Ning Jin, Ping Xue, Sheetal Bhan, Shabina Roohi Ahmed, D. Marc Rosen, Adam Schayowitz, Douglas P. Clark, Barry D. Nelkin> ;Oncology Reports. 2015 Nov 1
Effect of community-based newborn care on cause-specific neonatal mortality in Sylhet district, Bangladesh: findings of a cluster-randomized controlled trial.
Baqui, A. H.,Williams, E.,El-Arifeen, S.,Applegate, J. A.,Mannan, I.,Begum, N.,Rahman, S. M.,Ahmed, S.,Black, R. E.,Darmstadt, G. L.> ;J Perinatol. 2015 Nov 06
32 citations
A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours.
Breelyn A. Wilky, Michelle A. Rudek, Shabina Ahmed, Daniel A. Laheru, David Cosgrove, Ross C. Donehower, Barry D. Nelkin, Douglas W. Ball, Lawrence A. Doyle, Helen X. ...> ;British Journal of Cancer. 2015 Jan 6
57 citations
Incidentally Discovered Medullary Thyroid Cancer: Diagnostic Strategies and Treatment
Shabina Roohi Ahmed, Douglas W. Ball> ;The Journal of Clinical Endocrinology and Metabolism. 2011 Feb 23
Join now to see all

Press Mentions

Affirming Treatment: An endocrinologist helps transgender patients Blossom into their true selvesOctober 5th, 2022
The Most Important Things to Know About Diabetes Signs and SymptomsOctober 5th, 2022